Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 1;30(6):5379-5394.
doi: 10.3390/curroncol30060408.

Progress toward Health System Readiness for Genome-Based Testing in Canada

Affiliations
Review

Progress toward Health System Readiness for Genome-Based Testing in Canada

Don Husereau et al. Curr Oncol. .

Abstract

(1) Background: Genomic medicine harbors the real potential to improve the health and healthcare journey of patients, care provider experiences, and improve the health system efficiency-even reducing healthcare costs. There is expected to be an exponential growth in medically necessary new genome-based tests and test approaches in the coming years. Testing can also create scientific research and commercial opportunities beyond healthcare decision making. The purpose of this research is to generate a better understanding of Canada's state of readiness for genomic medicine, and to provide some insights for other healthcare systems. (2) Methods: A mixed-methods approach of a review of the literature and key informant interviews with a purposive sample of experts was used. The health system readiness was assessed using a previously published set of conditions. (3) Results: Canada has created some of the established conditions, but further action needs to be taken to improve the state of readiness for genome-based medicine. The important gaps to be filled are the need for linked information systems and data integration; evaluative processes that are timely and transparent; navigational tools for care providers; dedicated funding to facilitate rapid onboarding and support test development and proficiency testing; and broader engagement with innovation stakeholders beyond care providers and patients. These findings highlight the role of the organizational context, social influence, and other factors that are known to affect the diffusion of innovation within health systems.

Keywords: biomedical; clinical governance; diagnostic molecular pathology; diagnostic services; financial support; genetic services; genetic testing; health technology; healthcare innovation; technology assessment.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following conflicts of interest. D.H. and L.S. report funding, outside the submitted work, from various pharmaceutical companies with an interest in genome-based testing and precision medicine. D.S.S. is a salaried employee of Menarini Silicon Biosystems, Inc. (Huntingdon Valley, PA, USA) which is a commercial diagnostic manufacturer/clinical laboratory. V.M. advises a range of companies, including those with products and services related to the subject of this paper. V.M. holds, and has held shares in health data, health services, healthcare consultancy, and biotech companies, and serves or has served in paid non-executive director roles and paid advisory roles in such companies. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Number of necessary conditions for health system readiness for genome-based medicine established by province. Lightest shade indicates the condition does not exist or needs significant improvement (‘needs improvement’). Intermediate shade indicates some aspects of the condition were established (‘partially established’), while the darkest colour indicates most or all aspects of the necessary condition were established (‘established’).

References

    1. Sikka R., Morath J.M., Leape L. The Quadruple Aim: Care, Health, Cost and Meaning in Work. BMJ Qual. Saf. 2015;24:608–610. doi: 10.1136/bmjqs-2015-004160. - DOI - PubMed
    1. Ginsburg G.S. Realizing the Opportunities of Genomics in Health Care. JAMA. 2013;309:1463–1464. doi: 10.1001/jama.2013.1465. - DOI - PubMed
    1. Sperber N.R., Carpenter J.S., Cavallari L.H., Damschroder L.J., Cooper-DeHoff R.M., Denny J.C., Ginsburg G.S., Guan Y., Horowitz C.R., Levy K.D., et al. Challenges and Strategies for Implementing Genomic Services in Diverse Settings: Experiences from the Implementing GeNomics In PracTicE (IGNITE) Network. BMC Med. Genom. 2017;10:35. doi: 10.1186/s12920-017-0273-2. - DOI - PMC - PubMed
    1. Skivington K., Matthews L., Simpson S.A., Craig P., Baird J., Blazeby J.M., Boyd K.A., Craig N., French D.P., McIntosh E., et al. A New Framework for Developing and Evaluating Complex Interventions: Update of Medical Research Council Guidance. BMJ. 2021;374:n2061. doi: 10.1136/bmj.n2061. - DOI - PMC - PubMed
    1. Husereau D., Steuten L., Muthu V., Thomas D.M., Spinner D.S., Ivany C., Mengel M., Sheffield B., Yip S., Jacobs P., et al. Effective and Efficient Delivery of Genome-Based Testing-What Conditions Are Necessary for Health System Readiness? Healthcare. 2022;10:2086. doi: 10.3390/healthcare10102086. - DOI - PMC - PubMed

Publication types